“The goal of the health equity analysis is to create additional transparency and identify disproportionate impacts of utilization management policies and procedures on enrollees who receive the Part D low-income subsidy, are dually eligible, or have a disability,” the agency wrote Nov. 6.
The health equity changes would be effective in contract year 2025 and are part of a broader proposed rule from CMS. Comments on the proposal are due by Jan. 5, 2024.
Three key proposals:
1. Medicare Advantage payers would be required to add a health equity expert to their utilization management committee.
2. The utilization management committee would have to conduct an annual health equity analysis of the insurers’ Medicare Advantage prior authorization policies and procedures. The analysis would examine the impact of prior authorization on enrollees with one or more of the following risk factors: eligibility for Part D low-income subsidies, dual eligibility for Medicare and Medicaid, or having a disability — compared to enrollees without those risk factors.
3. Payers would be required to publish the results of the analysis on their website.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
